logo-loader
viewCanafarma

Canafarma's DTC marketing strategy 'an important driver' for the company - Analyst Ed Stacey

Proactive Research analyst Ed Stacey says CanaFarma Hemp Products Corp (CSE:CNFA, FRA:4K9) has a vertically integrated ‘farm-to-table’ strategy encompassing cultivation, extraction/process, manufacture of branded consumer products and sales & marketing.

Stacey says the firm is differentiated by a powerful and tested direct-to-consumer (DTC) marketing engine, and a product range that is scientifically validated and of consistent quality.

 

Click here to read Ed Stacey's full initiation report

Quick facts: Canafarma

Price: 0.79 CAD

CSE:CNFA
Market: CSE
Market Cap: $147.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canafarma named herein, including the promotion by the Company of Canafarma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tiziana Life Sciences PLC's clinical plan is shaping up says analyst Emma Ulker

Proactive Research analyst Emma Ulker says Tiziana Life Sciences PLC (LON:TILS)(NASDAQ:TLSA) is driving forwards at speed with the clinical development plan for its fully-human mAb TZLS-501 COVID-19 treatment. She adds that with GMP-grade manufacturing already underway they've appointed a number...

3 hours, 35 minutes ago

2 min read